Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
43.1M
-
Shares change
-
+1.75M
-
Total reported value, excl. options
-
$149M
-
Value change
-
+$7.93M
-
Put/Call ratio
-
0.28
-
Number of buys
-
68
-
Number of sells
-
-79
-
Price
-
$3.47
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2025
224 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q3 2025.
Editas Medicine, Inc. - Common Stock (EDIT) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.1M shares
of 82.8M outstanding shares and own 52.03% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8.02M shares), VANGUARD GROUP INC (6.97M shares), Nuveen, LLC (2.09M shares), GEODE CAPITAL MANAGEMENT, LLC (2.04M shares), STATE STREET CORP (1.93M shares), TWO SIGMA INVESTMENTS, LP (1.58M shares), RENAISSANCE TECHNOLOGIES LLC (1.28M shares), TWO SIGMA ADVISERS, LP (1.21M shares), MORGAN STANLEY (1.09M shares), and BANK OF AMERICA CORP /DE/ (1.02M shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.